Intuitive Surgical Inc banner

Intuitive Surgical Inc
NASDAQ:ISRG

Watchlist Manager
Intuitive Surgical Inc Logo
Intuitive Surgical Inc
NASDAQ:ISRG
Watchlist
Price: 494.21 USD 0.43% Market Closed
Market Cap: $175.5B

Intuitive Surgical Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Intuitive Surgical Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.3B
CAGR 3-Years
-15%
CAGR 5-Years
-18%
CAGR 10-Years
-21%
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
-6%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$2.1B
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.6B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.8B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-8%
IDEXX Laboratories Inc
NASDAQ:IDXX
Research & Development
-$251.2m
CAGR 3-Years
0%
CAGR 5-Years
-12%
CAGR 10-Years
-10%
No Stocks Found

Intuitive Surgical Inc
Glance View

In the rapidly evolving landscape of medical technology, Intuitive Surgical Inc. stands as a pioneer, revolutionizing the way surgeries are performed through its groundbreaking robotic systems. Founded in 1995, the company has set the benchmark for minimally invasive surgery with its flagship product, the da Vinci Surgical System. This sophisticated platform integrates advanced robotics, 3D visualization, and intuitive controls to enable surgeons to perform intricate procedures with precision and control that far surpass conventional methods. By enhancing the dexterity of the human hand and allowing for remarkably steady movements, the system reduces the physical strain on surgeons while improving patient outcomes in terms of reduced recovery time, minimized scarring, and lower risk of infection. Intuitive Surgical’s business model is both innovative and practical, capitalizing on a combination of product sales, ongoing service agreements, and instrument and accessory sales. Initially, hospitals and medical centers invest significantly in acquiring the da Vinci Systems, providing Intuitive with substantial capital inflows. However, the true genius of the company's revenue model lies in its ecosystem approach; ongoing revenue is generated through the sale of disposable instruments and components needed for each surgery. Additionally, the firm offers extensive maintenance and support services, ensuring that healthcare providers maximize their return on investment while maintaining optimal performance of their surgical systems. This balanced model creates a consistent and reliable income stream, enhancing the company's financial stability and enabling it to invest continually in research and development.

ISRG Intrinsic Value
186.86 USD
Overvaluation 62%
Intrinsic Value
Price

See Also

What is Intuitive Surgical Inc's Research & Development?
Research & Development
-1.3B USD

Based on the financial report for Dec 31, 2025, Intuitive Surgical Inc's Research & Development amounts to -1.3B USD.

What is Intuitive Surgical Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-21%

Over the last year, the Research & Development growth was -14%. The average annual Research & Development growth rates for Intuitive Surgical Inc have been -15% over the past three years , -18% over the past five years , and -21% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett